Per author (- group) it is allowed to submit maximum 2 abstracts for oral presentations
A clear description of the design should be included
Do not only focus on statistical results, but also on its clinical relevance (expressed as eg. number needed to treat or minimal clinically important difference) and implications.
Abstracts cannot exceed a limit of 2000 characters including spaces (excluding title, authors and affiliations).
All abstracts undergo peer review process. Do not use names of authors, institutions or country in your abstract, otherwise it has to be rejected.
Do not use product names or brands in your abstract, otherwise your abstract it has to be rejected.
Your abstract should be structured as follows and each heading should be in a separate paragraph: Title Background Research question Design Methods Results Discussion
Standard abbreviations do not need explanation. Otherwise abbreviations must be defined in brackets after when first used in the text.
It is not recommended to submit result of one study dissipated into multiple abstracts
The use of References is discouraged.
An automatically generated confirmation will be sent to the email address of the contact person after an abstract submission.
Authors will be notified of the acceptance of their abstract by email in February 2020
After acceptance of your abstract the presenting author should register within two weeks. Otherwise the paper wil be rejected.